Joris Wilms
CIK 1753231 · SVP & CHIEF OPERATING OFFICER · last filed 2025-09-18
Joris Wilms is a SVP & CHIEF OPERATING OFFICER who has filed 11 SEC Form 4 insider transactions across 1 company since 2018. Across all open-market trades the lifetime net is −$73.5K, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
11
-$73.5K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Y-mAbs Therapeutics, Inc. (YMAB) Delisted | SVP & CHIEF OPERATING OFFICER | 52,100 | $8.61 | $448.6K | -$73.5K | 10 | 2025-01-22 |
Recent Filings
11 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-09-18 | — | Mixed | −52,100 | -$110.1K | |
| 2025-01-22 | Y-mAbs Therapeutics, Inc. (YMAB) Delisted | Grant (A) | +21,500 | $0 | EDGAR |
| 2024-08-27 | Y-mAbs Therapeutics, Inc. (YMAB) Delisted | Sell (S) | −5,000 | -$73.5K | EDGAR |
| 2024-01-22 | Y-mAbs Therapeutics, Inc. (YMAB) Delisted | Grant (A) | +17,800 | $0 | EDGAR |
| 2023-01-30 | Y-mAbs Therapeutics, Inc. (YMAB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-01-19 | Y-mAbs Therapeutics, Inc. (YMAB) Delisted | Grant (A) | +17,800 | $0 | EDGAR |
| 2022-04-28 | Y-mAbs Therapeutics, Inc. (YMAB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-12-16 | Y-mAbs Therapeutics, Inc. (YMAB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-12-16 | Y-mAbs Therapeutics, Inc. (YMAB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-12-11 | Y-mAbs Therapeutics, Inc. (YMAB) Delisted | Grant (A) | — | $0 | EDGAR |